Science News
from research organizations
Universal Influenza Vaccine Tested Successfully In Humans
- Date:
- January 25, 2008
- Source:
- Flanders Institute for Biotechnology
- Summary:
- Scientists report the successful conclusion of Phase I trials of the universal flu vaccine in humans. The universal influenza vaccine is intended to provide protection against all 'A' strains of the virus that causes human influenza, including pandemic strains. Therefore, this vaccine will not need to be renewed annually. The vaccine was tested at multiple centers in the US and involved 79 healthy volunteers. The trial results demonstrate that ACAM- FLU-ATM is well tolerated and immunogenic, and no significant side-effects were observed.
- Share:
FULL STORY
The British-American biotech company Acambis reports the successful conclusion of Phase I trials of the universal flu vaccine in humans. The universal influenza vaccine has been pioneered by researchers from VIB and Ghent University. This vaccine is intended to provide protection against all ‘A’ strains of the virus that causes human influenza, including pandemic strains. Therefore, this vaccine will not need to be renewed annually.
Story Source:
Materials provided by Flanders Institute for Biotechnology. Note: Content may be edited for style and length.
Cite This Page:
Flanders Institute for Biotechnology. "Universal Influenza Vaccine Tested Successfully In Humans." ScienceDaily. ScienceDaily, 25 January 2008. <www.sciencedaily.com
Flanders Institute for Biotechnology. (2008, January 25). Universal Influenza Vaccine Tested Successfully In Humans. ScienceDaily. Retrieved October 10, 2025 from www.sciencedaily.com
Flanders Institute for Biotechnology. "Universal Influenza Vaccine Tested Successfully In Humans." ScienceDaily. www.sciencedaily.com
Explore More
from ScienceDaily
RELATED STORIES